Cytheris SA
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cytheris.com
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 92
- Registration Number
- NCT01241643
- Locations
- 🇮🇹
San Raffaele Scientific Institute, Milano, Italy
🇿🇦Helen Joseph Hospital-Themba Lethu Clinic, Johannesbourg, South Africa
🇨🇭University of Zurich, Zurich, Switzerland
Study on Interleukin-7 (CYT107) in HIV Patients
- Conditions
- HIV
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 23
- Registration Number
- NCT01190111
- Locations
- 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
🇺🇸Niaid/Nih, Bethesda, Maryland, United States
🇺🇸Case Western Reserve University, Cleveland, Ohio, United States
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2009-12-07
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 24
- Registration Number
- NCT01027065
- Locations
- 🇫🇷
Hopital Henri Mendor-Service d'HepatoGastroEnterologie, Creteil, France
🇫🇷Hopital Michallon, Grenoble, France
🇫🇷Hopital de l'Hotel Dieu, Lyon, France
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 15
- Registration Number
- NCT01024894
- Locations
- 🇨🇳
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
🇨🇳Chi Mei Medical Center, Tainan, Taiwan
🇨🇳Cathay General Hospital, Taipe, Taiwan
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 10
- Registration Number
- NCT01025596
- Locations
- 🇫🇷
Hopital Jean Verdier, Bondy, France
🇫🇷Beaujon Hospital, Clichy, France
🇫🇷Hopital Kremlin Bicêtre, Kremlin Bicêtre, France
- Prev
- 1
- 2
- Next